Search for media from: "Bharathi Vennapusa"

Assay Implementation: IHC Assays

Short video on implementing IHC assays in the anatomic pathology laboratory. TE-US-01071

From  Bharathi Vennapusa on March 15th, 2021 0 likes 2 plays

CAP/ASCO HER2 2018 Guideline update and RocheHER2 Assays

Dr. Bharathi Vennapusa from Roche MSA discusses 2018 CAP/ASCO HER2 guideline update and how it pertains to Roche HER2 Assays. Content and approvals of any product related information is current as of…

From  Bharathi Vennapusa on November 20th, 2020 0 likes 7 plays

Case Study: Assessing PD-L1 in TNBC - Scoring cases with common staining patterns

Dr. Michael Lynch of Medical and Scientific Affairs for Roche Diagnostics reviews 3 cases that show the most common pattern of tissue staining a pathologist will see in the triple negative breast…

From  Bharathi Vennapusa on November 22nd, 2020 0 likes 3 plays

Case Study: Assessing PD-L1 in TNBC - Select cases with staining near the scoring algorithm cut-off

Dr. Michael Lynch of Medical and Scientific Affairs for Roche Diagnostics reviews 3 cases that show the borderline tissue staining of IC around 1% of tumor area that a pathologist will see in the…

From  Bharathi Vennapusa on November 22nd, 2020 0 likes 4 plays

Case Study: Assessing PD-L1 in TNBC. Moderate IC staining without TC staining

Dr. Michael Lynch of Medical and Scientific Affairs for Roche Diagnostics reviews 3 cases that show the most common tissue staining pattern a pathologist will see in the triple negative breast cancer…

From  Bharathi Vennapusa on November 22nd, 2020 0 likes 4 plays

Down the Ocular Episode # 2 - VENTANA PD-L1 (SP142) Assay in NSCLC Part 1

In this episode, Roche Tissue Diagnostics Medical and Scientific Affairs colleagues Bharathi Vennapusa, MD and Tabari Baker, PhD discuss the PD-L1 (SP142) assay in non-small cell lung cancer. Drs.…

From  Bharathi Vennapusa on November 20th, 2020 0 likes 4 plays

Down the Ocular Episode # 3 - VENTANA PD-L1 (SP142) Assay in NSCLC Part 2

This episode is part 2 in a series on the PD-L1 (SP142) assay in non small cell lung cancer. In this episode, Roche Tissue Diagnostics Medical and Scientific Affairs colleagues Bharathi Vennapusa, MD…

From  Bharathi Vennapusa on November 20th, 2020 0 likes 2 plays

Down the Ocular episode 4 - CAP_ASCO 2018 guidelines and Roche HER2 assays

This is episode 4 of the Down the Ocular podcast. In this episode, Roche Tissue Diagnostics Medical and Scientific Affairs colleagues Bharathi Vennapusa, MD and Tabari Baker, PhD discuss the 2018…

From  Bharathi Vennapusa on November 19th, 2020 0 likes 5 plays

Down the Ocular Episode-1-NTRK overview, testing methods and algorithms and pan-TRK IHC assay

Down the Ocular Episode # 2: VENTANA pan-TRK (EPR17341) Assay: This episode focuses on the NTRK fusions; their detection, the testing methodologies used, and their role in solid tumors. Dr. Bharathi…

From  Bharathi Vennapusa on October 10th, 2020 0 likes 25 plays

Down the Ocular Pilot Episode - Remote Digital Pathology Devices - Guidance during COVID-19 Pandemic

In this episode, Roche Tissue Diagnostics Medical and Scientific Affairs colleagues Bharathi Vennapusa, MD and Tabari Baker, PhD discuss the use of digital pathology devices during the COVID-19…

From  Bharathi Vennapusa on November 20th, 2020 0 likes 2 plays

ER/PgR Testing in Breast Cancer: CAP/ASCO 2020 Guideline update

Dr. Bharathi Vennapusa reviews CAP/ASCO 2020 guideline update for ER/PgR testing in breast cancer and how these guidelines pertain to Roche ER/PgR assays.

From  Bharathi Vennapusa on March 12th, 2021 0 likes 3 plays

Every Slide Tells a Story: Methods for Successful Immunohistochemical Staining

Review of preanalytic variables in immunohistochemical assay staining. TE-US-01089

From  Bharathi Vennapusa on March 15th, 2021 0 likes 3 plays

FDA classifications & Development of In Vitro Diagnostic Assays

Review of FDA classification of IVD assays, overview of clinical trial process as well as IVD development including analytical validation. TE-US-01092

From  Bharathi Vennapusa on March 16th, 2021 0 likes 0 plays

How to score the PD-L1 (SP263) Assay in Urothelial Carcinoma

US Medical and Scientific Affairs (MSA) pathologist Dr. Erin Marner provides an overview of the PD-L1 (SP263) Assay by reviewing two urothelial carcinoma cases. Common questions are addressed and…

From  Bharathi Vennapusa on December 2nd, 2020 0 likes 6 plays

Interpretation of VENTANA pan-TRK (EPR17341) Assay - digital case review

Dr. Bharathi Vennapusa from Roche MSA reviews example cases stained with VENTANA pan-TRK (EPR17341) Assay using digital slides. Content and approvals of any product related info is current as of the…

From  Bharathi Vennapusa on November 20th, 2020 0 likes 16 plays

Low Prevalence Biomarkers: Validation Approach

Validation approach for low prevalence biomarkers and biomarkers in rare diseases for IHC assays. TE-US-01072

From  Bharathi Vennapusa on March 15th, 2021 0 likes 4 plays